Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07845630 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study in Healthy People to Compare How 2 Different Formulations of Vicadrostat / Empagliflozin Tablets Are Taken up in the Body

Name: A Study in Healthy People to Compare How 2 Different Formulations of Vicadrostat / Empagliflozin Tablets Are Taken up in the Body — clinical trial record (NCT07845630)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorBoehringer Ingelheim

Started2026-10-14

View on ClinicalTrials.gov ↗

Boehringer Ingelheim

221 trials monitored

See 15 trials at risk

The main objective of this trial is to establish the bioequivalence of two different formulations of vicadrostat / empagliflozin in healthy male and female trial participants following oral administration.

Trial Details

NCT Number	NCT07845630
Lead Sponsor	Boehringer Ingelheim
Conditions	Healthy
Enrollment	36 participants
Start Date	2026-10-14
Primary Completion	2026-12-11 (estimated)
Study Completion	2026-12-21 (estimated)
Updated on ClinicalTrials.gov	2026-09-29